Stefan Lutz insider trades: Codexis (CDXS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stefan reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | CDXS | ↓ Sell | 5,862 | $1.13 | $7K | Direct | Feb 25, 2026 (1d) |
| Feb 6, 2026 | CDXS | ↓ Sell | 2,492 | $1.31 | $3K | Direct | Feb 9, 2026 (3d) |
| Jan 7, 2026 | CDXS | ↓ Sell | 4,685 | $1.70 | $8K | Direct | Jan 8, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CDXS insiders
Open-market trades in the last 12 months
About Stefan Lutz's insider trades
Stefan Lutz is Chief Scientific Officer at Codexis (CDXS). Since Jan 7, 2026, Stefan has reported no open-market purchases and 3 sales worth $18K on SEC Form 4. In the last 12 months: 3 sales ($18K).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.